XML 26 R15.htm IDEA: XBRL DOCUMENT v3.6.0.2
10. Segment and Geographic Information
 9 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Segment and Geographic Information

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

 

The Company operates a single segment business for product revenues, which consists of three geographical sales territories as follows:

 

   Three Months   Nine Months 
   Ended   Ended 
   December 31,   December 31, 
  2016   2015   2016   2015 
Geographic region                
United States  $1,671,000   $1,010,000   $4,741,000   $2,983,000 
Latin America   465,000    –    465,000    – 
Europe and Rest of World   1,038,000    1,202,000    2,952,000    2,725,000 
    3,174,000    2,212,000    8,158,000    5,708,000 
Product license fees and royalties   –    44,000    –    231,000 
Total product related revenues  $3,174,000   $2,256,000   $8,158,000   $5,939,000 

 

During the three and nine months ended December 31, 2016, the Company reported $465,000 of Latin America product revenue related to the Supply Agreement with Invekra.

 

In connection with the Company’s sale of its Latin American business to Invekra, product revenues were reclassified from continuing operations to discontinued operations as follows:

 

   Three Months   Nine Months 
   Ended   Ended 
   December 31,   December 31, 
   2016   2015   2016   2015 
Product revenues  $359,000   $1,260,000   $2,693,000   $4,085,000 
Product license fees and royalties   262,000    76,000    412,000    675,000 
Total product related revenues  $621,000   $1,336,000   $3,105,000   $4,760,000 

 

The following table shows the Company’s product license fees and royalties revenues by partner:

  

   Three Months   Nine Months 
   Ended   Ended 
   December 31,   December 31, 
  2016   2015   2016   2015 
Partner                
Exeltis  $–   $44,000   $–   $202,000 
Innovacyn   –    –    –    29,000 
Total product license fees and royalties  $–   $44,000   $–   $231,000 

 

The Company’s service revenues amounted to $187,000 and $227,000 for the three months ended December 31, 2016 and 2015, respectively.

 

The Company’s service revenues amounted to $638,000 and $855,000 for the nine months ended December 31, 2016 and 2015, respectively.